MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • MDS Virtual Congress 2021

    The pandemic stress impact on disease progression in COVID-19 seronegative patients with idiopathic Parkinson’s Disease.

    M. Hansen, T. Marques, C. Pauly, L. Delacour, C. Martin-Gallausiaux, P. Wilmes, R. Krüger, N J. Diederich (Strassen, Luxembourg)

    Objective: To investigate the impact of chronic stress (CS) induced by the present pandemic on the progression rates of motor and cognitive impairment, on neuro-inflammatory…
  • MDS Virtual Congress 2021

    Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease

    N. Witek, J. Joyce, J. Hawkins, Y. Liu, B. Ouyang, R. Patel, J. Borgia, J. Reiser, D. Hall (Chicago, USA)

    Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2021

    SARS CoV2 in older patients with Parkinson’s.

    M. Khwaja, T. Nanayakkara, G. Pun, M. Todd, A. Chatterjee, N. Butt, N. Virgincar (Reading, United Kingdom)

    Objective: To review the clinical presentation and management of SARS-CoV 2 in older patients with Parkinson’s during the first wave of the pandemic in West…
  • MDS Virtual Congress 2021

    INTERLEUKIN 4 (IL-4),INTERLEUKIN 1α (IL-1α) AND CORTISOL SERUM LEVELS IN PARKINSON’S DISEASE PATIENTS UNDERGOING DANCE THERAPY

    K. Marques, J. Duarte, G. Bahia, B. Dos Santos-Lobato, L. Krejcová, C. Bahia (Belém, Brazil)

    Objective: To identify changes in anti and pro-inflammatory cytokines and cortisol hormone levels in patients with Parkinson's disease undergoing dance therapy. Background: Parkinson’s disease(PD) pathophysiology…
  • MDS Virtual Congress 2021

    Clinical Outcomes in Parkinson’s with COVID 19 during the’ first wave’ in West Berkshire, United Kingdom (UK)

    M. Khwaja, A. Chatterjee, N. Butt, N. Virgincar, M. Todd, T. Nanayakkara, G. Pun (Reading, United Kingdom)

    Objective: To review the outcomes of COVID 19 during the first wave in patients with Parkinson’s in West Berkshire, UK. Background: UK is one of…
  • MDS Virtual Congress 2021

    Post-Covid-19 Parkinson’s disease: a Brazilian case series.

    J. Tavares, D. Oliveira, S. Gaspar, C. Gomes, M. Neto, P. Neto (Fortaleza, Brazil)

    Objective: To describe two patients with post-COVID-19 Parkinson’s disease (PD) and discuss their possible causes. Background: PD is a neurodegenerative disorder characterized by motor and…
  • MDS Virtual Congress 2021

    Ultrastructural Characterization of Monocytes in Parkinson’s Disease and GBA mutations

    GM. Riboldi, S. Dilipkumar, A. Sowa, A. Allen, K. Astudillo, J. Crary, S. Frucht, T. Raj, W. Janseen (New York, USA)

    Objective: To identify morphological changes in circulating CD14+ monocytes in manifesting and non-manifesting carriers of mutations of the GBA gene and Parkinson’s disease (PD). Background: Mutations of…
  • MDS Virtual Congress 2021

    Mutations in GBA and LRRK2 are not associated with increased inflammatory markers

    A. Thaler, N. Omer, N. Giladi, T. Gurevich, A. Bar Shira, O. Goldstein, M. Gana-Weisz, M. Kestenbaum, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, S. Shenhar-Tsarfaty, A. Mirelman (Tel-Aviv, Israel)

    Objective: To assess central and peripheral cytokines among Parkinson's disease (PD) patients with mutations in the LRRK2 and GBA genes as well as among non-manifesting…
  • MDS Virtual Congress 2020

    CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

    E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: The aims of the present study were to investigate the levels of inflammatory cytokines in the cerebrospinal fluid (CSF) of drug-naïve Parkinson's Disease (PD)…
  • MDS Virtual Congress 2020

    Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease

    J. Behnke, L. Rauschenberger, S. Knorr, J. Volkmann, C.W Ip (Wuerzburg, Germany)

    Objective: To study disease progression in the transgenic (tg) hm2-α-SYN-39 mouse model of Parkinson´s disease (PD) by assessment of motor performance, dopaminergic neurodegeneration and T…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 28
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley